BL
The startup has developed a bacterial diagnostic platform that provides accurate bacterial identification and antibiotic susceptibility testing within two hours. This rapid testing reduces misdiagnosis and optimizes antibiotic treatment, improving patient outcomes and minimizing unnecessary antibiotic use.
Updated 18 months ago
Funding
$2.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
RCFunding rounds are not available yet.
Founders
Product
Features
- The startup has developed a bacterial diagnostic platform that provides accurate bacterial identification and antibiotic susceptibility testing within two hours. This rapid testing reduces misdiagnosis and optimizes antibiotic treatment, improving patient outcomes and minimizing unnecessary antibiotic use.